Tandem MS for Drug Analysis

download Tandem MS for Drug Analysis

of 93

Transcript of Tandem MS for Drug Analysis

  • 8/2/2019 Tandem MS for Drug Analysis

    1/93

    1

    Introduction to Mass Spectrometry

    BioAnalytical Technologies (I) Pvt. Ltd.

    Navnath Jaybhaye Manager- Product development & Application

  • 8/2/2019 Tandem MS for Drug Analysis

    2/93

    2

    Agenda

    Introduction Overview of MS Ionization Techniques Mass Analyzers Quadrupole Operations Applications Of LCMS

  • 8/2/2019 Tandem MS for Drug Analysis

    3/93

    3

    Analytical Assays used in PharmaceuticalIndustry Labs for New Chemical Entities

    0

    98%

    0

    2%

    2006

    10%10%10%Immunoassay(ELISA/FPIA etc.)

    60-75%40-50%3%LC/MS/MS

    2%3%12%GC/MS

    20%50-60%75%HPLC(UV &Fluorescence)

    200019981990Method

  • 8/2/2019 Tandem MS for Drug Analysis

    4/93

    4

    Mass Spectrometers

    Separate and measures ions based on their mass-to-charge (m/z) ratio.

    Operate under high vacuum (keeps ions from bumping

    into gas molecules) Key specifications are resolution , mass measurement

    accuracy , and sensitivity .

    Several kinds exist: for analysis, quadrupole, time-of-flight (TOF) and ion traps are most used.

  • 8/2/2019 Tandem MS for Drug Analysis

    5/93

    5

    InletInlet DetectDetectMass

    AnalyzeMass

    AnalyzeIonizeIonize

    MSMS

    InletInlet FragmentFragmentMass

    Analyze

    Mass

    AnalyzeIonizeIonize

    MassAnalyze

    MassAnalyze

    DetectDetect

    MS1MS1 CollisionCell

    CollisionCell

    MS2MS2

    MS/MSMS/MS

    MS vs. MS/MS

    GCHPLCCE

    Separation Identification

  • 8/2/2019 Tandem MS for Drug Analysis

    6/93

    6

    CH3COCH3CH3COCH3

    SampleInlet

    SampleInlet

    CH 3+COCH 3CH3+COCH 3

    Ionization& Adsorption

    of Excess Energy

    Ionization& Adsorption

    of Excess Energy

    Mass AnalysisMass Analysis

    CH 3C+OCH 3CH3C+OCH 3

    +COCH 3+COCH 3

    +CH 3+CH3+COH+COH

    Fragmentation(Dissociation)Fragmentation(Dissociation)

    DetectionDetection

    Mass Spectrometry

  • 8/2/2019 Tandem MS for Drug Analysis

    7/93

    7

    Components of Tandem Mass Spectrometer

    CollisionCell

    MassSpectrometer

    MassSpectrometer

    Detector

    Ionization Source

    ESIAPPIAPCIMALDI

    ArgonXenon

    QuatrupoleMagnetic Sector

    Quatrupole

    Magnetic SectorTime-of-flight

    Collisioncell

    MS1MS2

  • 8/2/2019 Tandem MS for Drug Analysis

    8/93

    8

    Sample introduction

    Ion Souce Transforms sample molecules to ions Soft ionization

    Places positive or negative charge on the analyte withoutsignificantly fragmenting the analyte M+1 ion (or M-1 ion) No need to volatilize Down to fmol detection limits

    Atmospheric Pressure Ionization (API) Electrospray MALDI APCI APPI

  • 8/2/2019 Tandem MS for Drug Analysis

    9/93

    9

    The Abb Nolletexperimentedwith electrified liquids in the 18thcentury !

    He observed that when a personwas connected to a high-voltagegenerator he/she would not bleednormally after cutting ...blood

    sprayed from the wound !

    F. Lemire, LCGC Europe LC-MS Supplement,December 2001, p29-35

    The Macabre History of Electrospray

  • 8/2/2019 Tandem MS for Drug Analysis

    10/93

    10

    How Sample is IntroducedSample Inlet

    Ion Spray Probe

    Ion Spray Heater

    Heater

    Ion Spray Inlet

    The sample is heldon the surface of a

    capillary tube, afine wire, or a smallcup.

  • 8/2/2019 Tandem MS for Drug Analysis

    11/93

    11J. Zelene, Phys. Rev ., 10, 1-6 (1917)

    The Electrospray Phenomenon

  • 8/2/2019 Tandem MS for Drug Analysis

    12/93

    12

    Ionization Source

  • 8/2/2019 Tandem MS for Drug Analysis

    13/93

    13

    Sample ConeOrifice = 400m

    Sample ConeOrifice = 400m

    Spraying NeedleSpraying Needle

    VacuumIsolation Valve

    VacuumIsolation Valve

    Ionization Source

  • 8/2/2019 Tandem MS for Drug Analysis

    14/93

    14

    Ionization Methods .

    Gas Phase Ionization Electron Impact (EI) Chemical Ionization (CI)

    Spray Ionization / Atmospheric Pressure Ionization (API) Electrospray (ESI) / API Atmospheric Pressure Chemical Ionization (APCI) Atmospheric Pressure photo Ionization (APPI)

    Desorption Ionization

  • 8/2/2019 Tandem MS for Drug Analysis

    15/93

    15

    II. Spray Ionization/APIThe compound of interest in a volatile buffer mobilephase, is passed through heated, narrow bore tubingdirectly into the ion source of a mass spectrometer. Thesolution is vaporized in the tubing, and analyte ionsdesorb into the gas phase and pass into the massanalyzer.

    Electrospray (ESI) / API Atmospheric Pressure Chemical Ionization (APCI) Atmospheric Pressure photo Ionization (APPI)

  • 8/2/2019 Tandem MS for Drug Analysis

    16/93

    16

    Electrospray Ionization(ESI)

  • 8/2/2019 Tandem MS for Drug Analysis

    17/93

    17

    High voltage appliedto metal sheath (~4 kV)

    Sample Inlet Nozzle(Lower Voltage)

    Charged droplets

    ++

    ++

    +

    +

    +

    +

    + ++

    +

    +

    +

    + ++

    ++

    + +

    ++ +

    ++ +

    ++

    ++

    +

    +

    +

    +

    +

    +

    ++ +

    ++ +

    ++

    +

    MH +

    MH 3+

    MH 2+

    Pressure = 1 atmInner tube diam. = 100 um

    Sample in solution

    N2

    N2 gas

    Partialvacuum

    Electrospray ionization:

    Ion Sources make ions from sample molecules

  • 8/2/2019 Tandem MS for Drug Analysis

    18/93

    18

    TURBOIONSPRAY (TIS)

  • 8/2/2019 Tandem MS for Drug Analysis

    19/93

    19

    API 4000TM

    Turbo Ion Spray

  • 8/2/2019 Tandem MS for Drug Analysis

    20/93

    20

    ESI Spectrum of Trypsinogen (MW 23983)

    1599.8

    1499.9

    1714.1

    1845.91411.9

    1999.62181.6

    M + 15 H +

    M + 13 H +

    M + 14 H +M + 16 H +

    m/z Mass-to-charge ratio

  • 8/2/2019 Tandem MS for Drug Analysis

    21/93

    21

    A P C I

  • 8/2/2019 Tandem MS for Drug Analysis

    22/93

    22

    A P P I

  • 8/2/2019 Tandem MS for Drug Analysis

    23/93

    23

    hLaser

    1. Sample is mixed with matrix (X)and dried on plate.

    2. Laser flash ionizes matrixmolecules.

    3. Sample molecules (M) are

    ionized by proton transfer:XH+ + M MH+ + X.

    MH+

    +/- 20 kV Grid (0 V)

    Sample plate

    M A L D I : M a

    t r i x

    A s s

    i s t e d L a s e r

    D e s o r p

    t i o n

    I o n

    i z a

    t i o n

  • 8/2/2019 Tandem MS for Drug Analysis

    24/93

    24

    The mass spectrum shows the results

    R e

    l a t i v e

    A b u n

    d a n c e

    Mass (m/z)

    0

    10000

    20000

    30000

    40000

    50000 100000 150000 200000

    MH +

    (M+2H) 2+

    (M+3H) 3+

    MALDI TOF spectrum of IgG

  • 8/2/2019 Tandem MS for Drug Analysis

    25/93

    25

    Differential vacuum in MS

    OR

    RNG

    QO

    IQ1

    ST RO1IQ2 RO2 IQ3

    RO3

    DF

    DET

    1x10 -5 torr

    Collision Cell (N 2)

    1-5 x 10 -4 torr

    1 torr

    8 x 10 -3 torr

    Q1 Analyzer Q3 AnalyzerCollisionalFocussing

    DP-FP

    Turbo

    Roughing pump

    1-2 x 10 -5 torr

  • 8/2/2019 Tandem MS for Drug Analysis

    26/93

    26

    Significance of vacuum

    A vacuum is necessary to permit ions to reach thedetector.

    It reduces or eliminates the chances of ion collisions

    with mass analyzer. The major reason for maintaining high vacuum is to

    increase the mean-free path of ions. Increases sensitivity and resolution of Mass

    Spectrum .

  • 8/2/2019 Tandem MS for Drug Analysis

    27/93

    27

    Types Of Analyzers

    Quadrupole Ion Trap Time-of-flight

  • 8/2/2019 Tandem MS for Drug Analysis

    28/93

    28

    Analytical Quadrupole

  • 8/2/2019 Tandem MS for Drug Analysis

    29/93

    29

    Schematic Diagram of Triple quad

    Instrument

  • 8/2/2019 Tandem MS for Drug Analysis

    30/93

    30

    Quadrupole TheoryPre-filter Quadrupole Mass Filter Stable Trajectory

    Unstable Trajectories

    Only ions with the correct m/z values have stabletrajectories within an RF/DC Quadrupole field.Ions with unstable trajectories collide with the rods, orthe walls of the vacuum chamber, and are neutralised.

  • 8/2/2019 Tandem MS for Drug Analysis

    31/93

    31

    1. Quadrupole

  • 8/2/2019 Tandem MS for Drug Analysis

    32/93

    32

    Advantages Relatively small and low-cost systems Low-energy collision-induced dissociation (CID) MS/MS Triple quadrupole and hybrid mass spectrometers.

    LimitationsLimited resolutionPeak height vs. mass response must be 'tuned'.Not well suited for pulsed ionization methods

    Applications Majority of benchtop GC/MS and LC/MS systems

    Triple quadrupole MS/MS systemsquadrupole hybrid MS/MS systems

    Quadrupole: Pros & Cons

  • 8/2/2019 Tandem MS for Drug Analysis

    33/93

    33

    Tandem Quadrupole

    CollisioncellMS1 MS2

  • 8/2/2019 Tandem MS for Drug Analysis

    34/93

    34

    Components of Tandem Mass Spectrometer

    CollisionCell

    MassSpectrometer

    MassSpectrometer

    Detector

    Ionization Source

    ESIAPPIAPCIMALDI

    ArgonXenon

    QuatrupoleMagnetic Sector

    Quatrupole

    Magnetic SectorTime-of-flight

    Collisioncell

    MS1MS2

  • 8/2/2019 Tandem MS for Drug Analysis

    35/93

    35

    Operation Modes

    Product Ion Scanning Analyzes all products of a single precursor

    Precursor Ion Scanning Analyzes all precursors of a single charged product

    Neutral Loss Scanning Analyzes all precursors of a single uncharged product

    Multiple Reaction Monitoring Analyzes for specific precursors producing specificproducts.

  • 8/2/2019 Tandem MS for Drug Analysis

    36/93

    36

    SCANNING MODE: The first quadrupole massanalyzer is Scanning over a mass range. Thecollision cell and the second quadrupole massanalyzer allow all ions to pass to the detector.

    SCANNING MODE: The first quadrupole massanalyzer is Scanning over a mass range. Thecollision cell and the second quadrupole massanalyzer allow all ions to pass to the detector.

    MS1 MS2Collision

    Cell

    Scanning Rf only, pass all masses

    CollisioncellMS1 MS2

    F u

    l l S c a n

    A c q u

    i s i t i o n

    M o d e

  • 8/2/2019 Tandem MS for Drug Analysis

    37/93

    37

    Mass Spectrum: Progesterone

    200 220 240 260 280 300 320 340 360 380 400m/z0

    100

    %

    315.1

    316.1

    [M+H]+

    O

    O

    CH3

    CH3CH3

    F u

    l l S c a n

    A c q u

    i s i t i o n

    M o

    d e

  • 8/2/2019 Tandem MS for Drug Analysis

    38/93

    38

    Static (m/z 315.1) Scanning

    The first quadrupole mass analyzer is fixed at the mass-to-chargeratio ( m/z ) of the precursor ion to be interrogated while the secondquadrupole is Scanning over a user-defined mass range.

    The first quadrupole mass analyzer is fixed at the mass-to-chargeratio ( m/z ) of the precursor ion to be interrogated while the secondquadrupole is Scanning over a user-defined mass range.

    Argon gasArgon gas

    PrecursorPrecursorProductsProducts

    CollisioncellMS1 MS2

    P r o

    d u c

    t i o n s c a n n

    i n g

  • 8/2/2019 Tandem MS for Drug Analysis

    39/93

    39

    Product Ion Spectrum: Progesterone

    300 305 310 315 320 325 330m/z0

    100

    %

    315.1

    316.1

    Mass Spectrum fromMS1

    100 125 150 175 200 225 250 275 300 325m/z0

    100

    %

    109.097.0

    Product ion spectrum from MS2 P r o

    d u c

    t i o n s c a n n

    i n g

    Product ions

    OCH

    2

    CH2

    CH3

    O

    CH3

    CH3

    O

    O

    CH 3

    CH3CH3

    Precursor ion

  • 8/2/2019 Tandem MS for Drug Analysis

    40/93

    40

    Static Scanning

    Precursor Ion Scan

    The first quadrupole mass analyzer is Scanning a mass range while thesecond quadrupole is fixed, or Static , at the mass-to-charge ratio ( m/z )of a product ion known to be common to the analytes in a mixture.

    The first quadrupole mass analyzer is Scanning a mass range while thesecond quadrupole is fixed, or Static , at the mass-to-charge ratio ( m/z )of a product ion known to be common to the analytes in a mixture.

    Argon gasArgon gas

    Pr ecur sor sPr ecur sor s

    Pr oductPr oduct

    CollisioncellMS1 MS2

    P r e c u r s o r

    i o n

    s c a n n i n g

  • 8/2/2019 Tandem MS for Drug Analysis

    41/93

    41

    - RCOOH

    -(CH3)3N-C4H8

    - RCOOH

    -(CH3)3N-C4H8

    CIDCID

    ButylationButylation

    CH2CH2 CHCH CHCH

    RCOORCOO HH

    COOHCOOH(CH3)3N(CH3)3N

    CH2CH2 CHCH CHCH

    RCOORCOO HH

    COOC4H8COOC4H8(CH3)3N(CH3)3N

    CH2CH2 CHCH CHCH COOHCOOH[[ ]+]+

    (m/z 85)(m/z 85)

    AcylcarnitinesDerivatization and Fragmentation

    All compounds of this typefragment to produce the 85ion.

    P r e c u r s o r

    i o n

    s c a n n i n g

    R=0 to 18 carbon alkyl chain.

  • 8/2/2019 Tandem MS for Drug Analysis

    42/93

    42225 250 275 300 325 350 375 400 425 450 475 500

    m/ 0

    100

    %

    d3-free carnitin ed3-free carnitin e

    C2 carnitineC2 carnitine

    C16 carnitineC16 carnitine

    d3-C3 carnitined3-C3 carnitine

    d3-C8 carnitined3-C8 carnitine

    d3-C16 carnitined3-C16 carnitine

    Normal Acylcarnitine Profile

    P r e c u r s o r

    i o n

    s c a n n i n g

  • 8/2/2019 Tandem MS for Drug Analysis

    43/93

    43

    Scanning (M-102) Scanning (M)

    In a neutral loss scan the two quadrupole mass filters are Scanning synchronously at a user-defined offset. The neutral loss is known to becommon to the analytes in a mixture.

    Argon gas

    Pr ecur sor s

    Pr oduct s

    CollisioncellMS1 MS2

    N e u

    t r a

    l l o s s s c a n n

    i n g

  • 8/2/2019 Tandem MS for Drug Analysis

    44/93

    44

    Neutral and Acidic Amino Acids

    Derivatization and Fragmentation (Generic )

    +

    Butanol

    CH3

    OH

    O

    OHCH3

    Butyl formateNeutral loss of

    102Da

    +

    O

    NH2

    OHR

    Neutral or Acidic AA

    HCl

    Amino acid butyl ester

    O

    NH2

    OR

    CH3

    Neutral or Acidic AA

    O

    NH3+

    OR

    CH3Fragmentation

    Fragment

    NH2+

    R

  • 8/2/2019 Tandem MS for Drug Analysis

    45/93

    45140 160 180 200 220 240 260 280

    m/z0

    100

    %

    d3-Leu

    d4-Ala

    d3-Met

    d5-Phe d6-Tyr

    d8-Val

    Gly

    Ser

    Pro

    Glu

    Deuterated internal standards for quantification

    Normal Amino Acid Profile

    N e u

    t r a

    l l o s s s c a n n

    i n g

  • 8/2/2019 Tandem MS for Drug Analysis

    46/93

    46

    Both the first and second quadrupole mass analyzers are held Static atthe mass-to-charge ratios ( m/z ) of the precursor ion and the mostintense product ion, respectively.

    Both the first and second quadrupole mass analyzers are held Static atthe mass-to-charge ratios ( m/z ) of the precursor ion and the mostintense product ion, respectively.

    Static (m/z 315.1) Static (m/z 109.0)

    Argon gasArgon gas

    Precursor(s)Precursor(s)Product(s)Product(s)

    CollisioncellMS1 MS2

    M u

    l t i p l e

    R e a c

    t i o n

    M o n

    i t o r i n g

  • 8/2/2019 Tandem MS for Drug Analysis

    47/93

    47

    Collision induced dissociation

    Collision conditions (FRAGMENTATION) is controlled by altering:

    The collision energy (speed of the ions as they enter the cell) Number of collisions undertaken (collision gas pressure)

    Argon gas

    O

    O

    CH 3

    CH3CH3

    Precursor ion Product ions

    OCH

    2

    CH2

    CH3

    O

    CH3

    CH 3

    In the collision cell, the TRANSLATIONAL ENERGY ofthe ions is converted to INTERNAL ENERGY .

  • 8/2/2019 Tandem MS for Drug Analysis

    48/93

    48

    2. Quadrupole Ion Trap

    In an Ion trap the ions are trapped in a radio-frequency quadrupolefield.

    The ions are then ejected detected as the radio frequency field isscanned.

    Ions are dynamically stored in a three-dimensional quadrupole ionstorage device.

    The RF and DC potentials can be scanned to eject successivemass-to-charge ratios from the trap into the detector.

  • 8/2/2019 Tandem MS for Drug Analysis

    49/93

    49

    Q0 Q1 Q2 Q3

    QTRAP Linear ion trap

    N2 CAD Gas

    linear ion trap 3x10 -5 Torr

    ion selection

    Ion accumulation

    Fragmentation

    Exit lens

  • 8/2/2019 Tandem MS for Drug Analysis

    50/93

    50

    3-D Ion Trap Schematics

    Heated quartzcapillary

    Ion TrapID ~ 10 mm

    MS ScanProduct Ion ScanMS n

  • 8/2/2019 Tandem MS for Drug Analysis

    51/93

    51

    Q-Ion Trap- Pros & Cons

    Benefits

    High sensitivityMulti-stage MS

    Limitations

    Poor quantitation.Subject to space charge effects and ion moleculereactions.Collision energy not well-defined in CID MS/MS.

    Applications

    Compact mass analyzer

  • 8/2/2019 Tandem MS for Drug Analysis

    52/93

    52

    3. Time-of-Flight (TOF)

    Time of flight mass spectrometer measures the mass-dependent time

    It takes ions of different masses to move from the ion

    source to the detector.

    Ions are either formed by a pulsed ionization method(usually MALDI), or various kinds of rapid electric fieldswitching are used as a 'gate' to release the ions fromthe ion source in a very short time.

  • 8/2/2019 Tandem MS for Drug Analysis

    53/93

    53

    TOF - Pros & Cons

    BenefitsFastest MS analyzerWell suited for pulsed ionization methodsHigh ion transmissionHighest practical mass range of all MS analyzers

    LimitationsRequires pulsed ionization method or ion beam switchingFast digitizers used in TOF can have limited dynamic rangeLimited precursor-ion selectivity for most MS/MS experiments

    Applications

    MALDI systemsVery fast GC/MS systems

  • 8/2/2019 Tandem MS for Drug Analysis

    54/93

    54

    Mass analysis is the separation of bunches orstreams of ions according to their individual

    mass-to-charge (m/z) ratio

    The mass analyzer sorts the ions according tom/z and the detector records the abundance ofeach m/z.

    DETECTORS

  • 8/2/2019 Tandem MS for Drug Analysis

    55/93

    55

    Detectors are eyes of the Instrument

    Once the ion passes through the mass analyzerit is then detected by the ion detector,

    The final element of the mass spectrometer.

  • 8/2/2019 Tandem MS for Drug Analysis

    56/93

    56

    METHODS OF I ON DETECTI ON

    The detector generates a signal from incidentions by two ways:

    1. Inducing current generated by a moving charge

    2. Generating secondary electrons, which are furtheramplified.

  • 8/2/2019 Tandem MS for Drug Analysis

    57/93

    57

    Current generated by a moving charge .

    Flow of electrons in the wire isdetected as an electric currentwhich can be amplified andrecorded.The more ions arriving, the greaterthe current.Variation in the magnetic field,changes the flow of ion stream tothe detector which produce acurrent proportional to the numberof ions arriving.Timing mechanisms, whichintegrate those signals with thescanning voltages, allow theinstrument to report which m/zstrikes the detector

  • 8/2/2019 Tandem MS for Drug Analysis

    58/93

    58

    Detector operates by producing a signal current fromincident ions by generating secondary electrons, whichare further amplified

    Key part of such type of detectors is a dynode. Dynode is electron-multiplying electrode.

    Current generated by secondary electrons

    Incoming Ion

    Secondary Electrons

  • 8/2/2019 Tandem MS for Drug Analysis

    59/93

    59

    Contd

    Process of Secondary electron emission. Electrons accelerated, and strike the surface of

    electrode (dynode) Energy deposited by the incident electrons result in

    re- emission

    Secondaryelectrons

    Electrodesurface(dynode) Dynodes

    ForAmplification

  • 8/2/2019 Tandem MS for Drug Analysis

    60/93

    60

    Certain of thesecharacteristics are common,like :

    high sensitivity

    linear, quantitative response

    Some detectors aredesigned for specificfunctions or applications.

    CHARECTERISTICS

  • 8/2/2019 Tandem MS for Drug Analysis

    61/93

    61

    Electron multiplier is made up of a series of dynodesmaintained at ever increasing potentials.

    Typical amplification or current gain of an electronmultiplier is one million.

    Electron Multipliers contd

  • 8/2/2019 Tandem MS for Drug Analysis

    62/93

    62

    Two major modifications:

    Multiple-dynode type

    Continuous-dynode type

    Electron Multipliers contd

  • 8/2/2019 Tandem MS for Drug Analysis

    63/93

    63

    1. Multiple-dynode type EM

    Incoming ion reaches the first dynode

    Ejects several other electrons by secondary emission.

    This process repeated at each succeeding dynode having

    a higher potential than the preceding dynode. When it arrives at the anode, the electron flow is

    significantly amplified

    Incident ions

    Cathode Anode

  • 8/2/2019 Tandem MS for Drug Analysis

    64/93

    64

    2. Continuous Electron Multiplier

    Contains a glass pipe with a coating on its inner surface

    The electron flow moves along the pipe, reflecting fromthe inner wall and progressively gaining electrons

    The electrical field accelerating the flow is formed bythe high voltage applied across the two ends

    resistive-material

    inner coating

  • 8/2/2019 Tandem MS for Drug Analysis

    65/93

    65

    Advantages: Very high current gain Sensitive Fast

    Disadvantage: Short lifetime Requires good vacuum to operate

    Electron multipliers are widely used in Quadrupole andIon trap Instruments.

    Features of Electron Multipliers

  • 8/2/2019 Tandem MS for Drug Analysis

    66/93

    66

    Channel Electron Multiplier

    A modified continuousdynode electron multiplier

    Comprised of "the channel,"a hollow, cornucopia-shapedtube made of semi conductiveglass.

  • 8/2/2019 Tandem MS for Drug Analysis

    67/93

    67

    Channel Electron Mult iplier contd ..

    IONS

    The primary incoming ions passes through the inlet and strikes thesurface of the CEM

    The collision energy eject an electron from CEM wall Ejected electrons accelerated into interior of CEM

    Trigger secondary emission and the process continues to produce anoutput electron

  • 8/2/2019 Tandem MS for Drug Analysis

    68/93

    68

    RECORDER

    Analogue signal is produced by the detector. Analogue Digital Converter sends the output to the

    computer.

    Detector ADC Recorder

  • 8/2/2019 Tandem MS for Drug Analysis

    69/93

    69

    IDENTIFICATION

    Single MS

    Specificity

    Precursor Ion

    Neutral Loss

    Enh.Multi Charged

    QUANTITATION

    SIM or MRM

    AUTOMATION

    I nfo. D ep. Acquisition

    Met ID

    CHARACTERIZATION

    High Sensitivity Full Scan MSMS

    MS 3 Capabilities

    Plug & Play Sources

    TurboIonspray Heated Nebulizer (APCI)

    Nanospray

    Integrated Syringe pump

    Built-in divert valve

  • 8/2/2019 Tandem MS for Drug Analysis

    70/93

    70

    Where are Mass Spectrometer Used

    Biotechnology: the analysis of Proteins,Peptides, Oligonucleotides

    Pharmaceutical: Drug Discovery, Combinatorial

    Chemistry, Pharmacokinetics, Drug Metabolism

    Clinical: neonatal Screening, Hemoglobinanalysis, drug testing

    Environmental: PAHs, PCBs, water quality.Food contamination

    Geological: Oil composition

  • 8/2/2019 Tandem MS for Drug Analysis

    71/93

    71

    How can Mass Spectrometry helpBiochemists

    Accurate molecular weight measurements : sample confirmation, todetermine the purity of a sample, to verify amino acid substitutions, todetect post-transnational modifications, to calculate the number ofdisulfide bridges

    Reaction monitoring: to monitor enzyme reactions, chemicalmodification, protein digestionAmino acid sequencing :sequence confirmation, de novocharacterization of peptides, identification of proteins by databasesearching with a sequence tag from a proteolytic fragment

    Oligonucleotide sequencing :the characterization or quality control ofOligonucleotides

    Protein structure :protein folding monitored by H/D exchange, protein-ligand complex formation under physiological conditions,macromolecular structure determination

  • 8/2/2019 Tandem MS for Drug Analysis

    72/93

    72

    LC-MS/MS

    Selectivity and Sensitivity comparisons

    Application Area: Environmental

    Application Example 1

  • 8/2/2019 Tandem MS for Drug Analysis

    73/93

    73

    LC/MS or LC/MS/MS?Selectivity & Sensitivity

    Quantitation of 3 pesticides in a surfacewater extract Simazine; Atrazine and

    Metabenzthiazuron

    Chromatographic and Mass Specconditions: Ionization technique : APCI

  • 8/2/2019 Tandem MS for Drug Analysis

    74/93

    74

    Product Ion Spectra

    Simazine (202-132)

    Metabenzthiazuron (222 - 165)

    Atrazine (216-174 )

    MH+

    MH+

    MH+

    N2NO2 NO2

    MSMS Product Ion Scan= NO2

    Q1 fixed, = CAD Collision Q3 scanningNO2

  • 8/2/2019 Tandem MS for Drug Analysis

    75/93

    75

    Simazine in surface water extract(50 pg injected on column)

    (SIM MODE; m/z 202) (MRM MODE; m/z 202-174)

    API 150 EX TM LC/MS System API 2000 TM LC/MS/MS System

  • 8/2/2019 Tandem MS for Drug Analysis

    76/93

    76

    Application Example 2

    LC-MS/MS

    Impurity profiling

  • 8/2/2019 Tandem MS for Drug Analysis

    77/93

    77

    Impurity/Degradation Product Profiling

    Experimental Conditions: 4 Commercially available OTC Melatonin Tablet

    preparations

    LC Column: 4.6 x 50 mm Chromolith SpeedRodRP-18 Targeted analysis using MRM as survey for

    known impurities and EMS for profiling in IDAfollowed by EPI

    Confirmation of impurity/degradation product byMS/MS using EPI

  • 8/2/2019 Tandem MS for Drug Analysis

    78/93

    78

    Multiple MRMs (1)

    Second DependentScan (s)

    IDA CriteriaLevel 1

    EMS (2)

    Dependent Scan (s)

    Enhanced Resolution

    Add toExclusion ListIDA CriteriaLevel 2

    Dependent Scan (s)Dependent Scan (s)Dependent Scan (s)

    Second DependentScan (s)

    Second DependentScan (s)

    Impurity/Degradation Product Profiling

    For known impurities,targeted MRM analysiscan be used. At the sametime an EMS survey scan

    can search for unknownimpurities

    for unknown impurities,IDA triggered MS/MS and

    MS3 information can becollected to aid inidentification.

  • 8/2/2019 Tandem MS for Drug Analysis

    79/93

    79

    H 3C O NH

    O

    HN

    OH

    H OOH

    HN

    NH

    O

    H 3C O

    oxidation Impurities249 m/z

    di-oxidation Impurity265 m/z

    Targeted MRMKnown Impurities

    EMSUnknown Impurities

    Impurity/Degradation Product Profiling

  • 8/2/2019 Tandem MS for Drug Analysis

    80/93

    80

    +E P I (477.00) C h arge (+ 2) C E (3 0): E xp 3 , 5 .568 m in from S am ple 1 (S tre ssed 10 ng/uL) o f S tre ss ... M ax. 1 .6e5 cps .

    60 80 100 120 140 160 180 200 220 240 260 28 0 30 0 320 340 360 380 400 420 4 40 4 60 4 80 500m/z, amu

    5 %

    10%

    15%

    20%

    25%

    30%

    35%

    40%

    45%

    50%

    55%

    60%

    65%

    70%

    75%

    80%

    85%

    90%

    95%100% 245.0

    186.0202.9

    228.0 477.2405.2160.0

    273.0 418.3267.1233.0 329.0

    H3COHN

    ON

    H 3CO NH

    ON

    245

    Melatonin-FormaldehydeImpurity477 m/z

    EPI

    Impurity/Degradation Product Profiling

  • 8/2/2019 Tandem MS for Drug Analysis

    81/93

    81

    X IC o f + E M S : E x p 1 , 2 4 9 .0 a m u fr o m S a m p le 9 ( M e la to n in T a b le t (1 0 0 n g /u L ) ID A E M S_ E R _ E P I w i. . . M a x . 8 .3 e 6 c p s .

    1 2 3 4 5 6 7 8 9Ti m e , m i n

    0 .0

    5 . 0 e 5

    1 . 0 e 6

    1 . 5 e 6

    2 . 0 e 6

    2 . 5 e 6

    3 . 0 e 6

    3 . 5 e 6

    4 . 0 e 6

    4 . 5 e 6

    5 . 0 e 6

    5 . 5 e 6

    6 . 0 e 6

    6 . 5 e 6

    7 . 0 e 6

    7 . 5 e 6

    8 . 0 e 68 . 3 e 6

    2 . 8 6

    7 . 2 1

    6 . 9 1

    3 . 8 1

    XICs of peaks present in Sample,but not Control.

    MS/MS information collected through IDA

    software can help with data analysis through sampleand control comparison for degradation products

    Impurity/Degradation Product Profiling

  • 8/2/2019 Tandem MS for Drug Analysis

    82/93

    82

    Specificity of Detection for LC

    UV chromophore all compounds with a chromophore responding at the

    selected wavelength will interfere

    MS molecular mass interference from isobaric compounds chemical noise

    MS/MS molecular mass and structuralinformation interference from structural isomers only

  • 8/2/2019 Tandem MS for Drug Analysis

    83/93

    83

    1. Wash all glassware in methanol x2 and tert-butyl methyl ether (TBME) x2.2. Place 50 L of internal standard (in methanol) into each screw-cap glass

    tube.3. Add 200 L Sirolimus calibrator (5x concentrated in methanol) or 200 L

    methanol for patient samples.4. Add 1.0mL blank whole blood to calibrators or 1.0mL patient whole blood .

    5. Add 2.0mL 0.1M ammonium carbonate buffer.6. Mix thoroughly.7. Add 7.0mL TBME and extract for 15min.8. Transfer upper layer to clean tube and re-extract lower layer with 7.0mL

    TBME.9. Combine TBME extracts and evaporate to dryness .10 . Redissolve residue in 5.0mL ethanol and evaporate to dryness .

    11 . Redissolve residue in 1.0mL ethanol, transfer to Eppendorf tube andevaporate to dryness .

    12 . Redissolve residue in 100 L 85% methanol.13 . Inject 80 L (equivalent to 800 L whole blood ) and analyse using two

    4.6mm x 250mm C18 columns connected in series (30min run time) .

    HPLC-UV Analysis of Sirolimus inWhole Blood

  • 8/2/2019 Tandem MS for Drug Analysis

    84/93

    84

    Sirolimus: HPLC - UV Example

  • 8/2/2019 Tandem MS for Drug Analysis

    85/93

    85

    Add ZnSO4

    Soln.

    Whole Blood(10 L - 40L)

    Add 2 volumes MeCNwith IS, Seal & Vortex Mix

    Centrifuge,Inject 5 - 20 L

    Immunosuppressant Sample PreparationLC-MS/MS Analysis

  • 8/2/2019 Tandem MS for Drug Analysis

    86/93

    86

    Sirolimus: MS Spectrum

    790 795 800 805 810 815 820 825 830 835 840 845 850m/z0

    100

    %

    821.5

    810.5

    822.5

    826.5

    827.5[M+H]+

    [M+NH4]+

    [M+Li]+

    [M+Na ]+

    [M+K]+

    F u

    l l S c a n

    A c q u

    i s i t i o n

    M o

    d e

    Sirolimus:

  • 8/2/2019 Tandem MS for Drug Analysis

    87/93

    87

    Sirolimus:LC-MS (SIM) vs LC-UV

    0

    100

    %SIR m/z 821

    30g / L

    1.5 min

    HPLC-UV

    HPLC-MS

    S i n g l e

    i o n m o n

    i t o r i n g

    ( M

    S )

  • 8/2/2019 Tandem MS for Drug Analysis

    88/93

    88

    Sirolimus: MS Spectrum

    790 795 800 805 810 815 820 825 830 835 840 845 850m/z0

    100

    %

    821.5

    810.5

    822.5

    826.5

    827.5[M+H]+

    [M+NH4]+

    [M+Li]+

    [M+Na ]+

    [M+K]+

    F u

    l l S c a n

    A c q u

    i s i t i o n

    M o

    d e

  • 8/2/2019 Tandem MS for Drug Analysis

    89/93

    89

    MS1 MS2Collision

    Cell

    Static (m/z 821.5) Scanning

    The first quadrupole mass analyzer is fixed, orStatic , at the mass-to-charge ratio ( m/z ) of theprecursor ion to be interrogated while the secondquadrupole is Scanning over a user-defined massrange.

    The first quadrupole mass analyzer is fixed, orStatic , at the mass-to-charge ratio ( m/z ) of theprecursor ion to be interrogated while the secondquadrupole is Scanning over a user-defined massrange.

    Ar (2.5 3.0e -3mBar)Ar (2.5 3.0e -3mBar)

    PrecursorPrecursorProductsProducts

    P r o d u c

    t i o n s c a n n

    i n g

  • 8/2/2019 Tandem MS for Drug Analysis

    90/93

    90

    790 795 800 805 810 815 820 825 830 835 840 845 850m/z0

    100

    %

    821.5

    810.5

    822.5

    826.5827.5

    Mass spectrum from MS1Mass spectrum from MS1

    200 250 300 350 400 450 500 550 600 650 700 750 800 850 900m/z0

    100

    %

    768

    576

    558548718 750

    786821

    Product ion spectrum from MS2Product ion spectrum from MS2

    P r o d u c

    t i o n s c a n n

    i n g

    NH4+

  • 8/2/2019 Tandem MS for Drug Analysis

    91/93

    91

    MS1 MS2Collision

    Cell

    Static (m/z 821.5) Static (m/z 768.5)

    Ar (2.5 3.0e -3mBar)Ar (2.5 3.0e -3mBar)

    Precursor(s)Precursor(s) Product(s)Product(s)

    MS/MS : Compound-Specific Monitoring

    M u

    l t i p l e

    R e a c t i o

    n M o n i t o r i n g

    Sirolimus

  • 8/2/2019 Tandem MS for Drug Analysis

    92/93

    92

    SirolimusLC-MS(SIM) vs LC-MS/MS (MRM )

    SIR m/z 821

    0.50 1.00 1.50Time0

    100

    %

    0

    100

    %

    0.50 1.00 1.50Time0

    100

    %

    0

    100

    %

    MRM m/z 821>768

    3g / L 30g / L

    M u

    l t i p l e

    R e a c t i o

    n M o n i t o r i n g

  • 8/2/2019 Tandem MS for Drug Analysis

    93/93

    93

    Questions please?...